APP and Alzheimer disease: In conclusion, our results suggested that ATF and GTF could protect the cells against Aβ toxicity, possibly by activating and suppressing the genes expression involved in the regulation of APP non-amyloidogenic and amyloidogenic processing pathways, respectively, thus indicating that it may be useful in AD treatment.